newsfilter
← Latest News
Business Wire·

Aptinyx to Participate in Piper Sandler 33rd Annual Virtual Healthcare Conference

Aptinyx Inc. (NASDAQ:APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that company management will participate in a fireside chat at the Piper